AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.

MAP Pharmaceuticals, Inc.

Home » NASDAQ » Healthcare » MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals, Inc., a development stage company, focuses on the development and commercialization of inhalation therapies for patients suffering from migraine.

  • Annual Reports
View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports